Medable

06/25/2026

The FDA's move toward real-time clinical trials highlights that the industry can no longer rely on static documents and manual handoffs to support modern study ex*****on.

Medable's DDF Agent helps create the machine-readable foundation needed to keep protocols, downstream systems, and operational workflows continuously aligned. This is essential for a future in which study data, endpoints, and safety signals must move with greater speed, consistency, and traceability to support real-time trial ex*****on and responsiveness.

👉 Learn more here: https://www.bioxconomy.com/clinical-and-research/medable-launches-ai-agent-to-convert-static-trial-protocols-into-machine-readable-structured-data
________

The DDF Agent creates machine-readable protocol data that automatically updates across connected systems and workflows

06/23/2026

Ambition is easy. Evidence is harder. 💯
Tomorrow, at Roche's Clinical Trial Innovation Summit, Medable's Andrew Mackinnon will walk through exactly how agentic AI moves from roadmap to reality in clinical research. He'll cover real deployments, in regulated environments, with outcomes you can actually point to.

If you're attending this event and serious about where your organization goes next with AI, add this session to your calendar today! 📅
________

06/22/2026

Oncology trials may screen 1 to 5 patients a day. Vaccine trials can screen and enroll up to 1,000 participants per day.

That level of scale demands rapid activation across multiple sites, real-time safety monitoring from day one, and an eCOA platform built to keep up.

See how Medable helped a top-5 pharma launch the infrastructure for true vaccine mega-trials, creating a blueprint now running across 3 additional studies, including one with 50,000 patients and 428 sites. 👇

Read here: https://www.medable.com/knowledge-center/long-form-case-study-scaling-global-vaccine-mega-trials-for-a-top-5-pharma
________

06/19/2026

Angie Maurer, VP of AI-enabled clinical development at Medable, explains the 3 structural barriers that kept protocol digitization out of reach—and why the convergence of LLMs, industry standards, and validated environments has finally changed the equation.

Watch here: https://www.youtube.com/watch?v=odZuRcI0PVE&t=20s
________

In this video interview from the 2026 DIA Global Annual Meeting, An...

06/15/2026

Today, we announce our Digital Data Flow (DDF) Agent, which automatically transforms static clinical trial protocols into structured, machine-readable data that can be continuously used across the clinical development lifecycle.

Traditionally, clinical trial protocols are static documents that require extensive manual interpretation and re-creation across many downstream systems. Medable’s DDF Agent converts protocol information into a CDISC USDM 4.0, standardized, structured JSON data format, which is foundational for automated and dynamic readiness and adaptivity throughout a clinical trial.

👉 Find out more here: https://www.medable.com/newsroom/medable-introduces-digital-data-flow-agent-laying-the-foundation-for-end-to-end-agentic-clinical-development
________

06/12/2026

Billions of dollars, years of development, and patient outcomes can hinge on the decisions made in the final stages of a program.

Next week in Cambridge, MA, our CCO Alison Holland sits down with the CEOs of Formation Bio and Saghmos Therapeutics, the president of ReAlta Life Sciences, and Takeda's head of neuroscience to discuss "Advancing Late-Stage Assets."

If you're at the Koch Institute on June 15-16 for MIT CEO, this is a conversation worth catching.

Add the session to your calendar here: longwoodhealthcareleaders.com/mitceo
________

06/11/2026

Onboarding. Integration. Governance. Change management.

Our Agentic Accelerator Program gives sponsors and CROs everything they need to deploy AI agents from day one, with a team that has skin in the game on your clinical outcomes.

Go from zero to scaled in weeks, not years. Learn more here: https://www.biospectrumasia.com/news/26/27743/medable-launches-agentic-accelerator-program-to-help-life-sciences-companies-deploy-agentic-ai-across-clinical-lifecycle.html
________

Medable has launched its Agentic Accelerator Program to help life sciences companies and CROs deploy agentic AI across clinical development workflows with onboarding, governance and integration support.

06/11/2026

To transform clinical development, we must increase both productivity and velocity. Find out how a top-10 global sponsor partnered with Medable to expand the number of oncology trials they could concurrently conduct and accelerate their timelines. 📈

👉 Access the case study here: https://www.medable.com/knowledge-center/long-form-building-a-scalable-oncology-engine-in-a-dynamic-market
________

06/09/2026

The difference between hoping for better study outcomes and driving them?

Control. 💯

Legacy eCOA keeps critical decisions hidden behind a vendor black box. Medable eCOA empowers sponsors to succeed with complete transparency, streamlined global deployments, and the ability to shape and validate ex*****on at every step.

See what's possible at medable.com!